DOK-FARMA, OOO, Moscow Oblast

Economic indicators

Net loss (RAS) of DOK-FARMA, OOO dropped over 2022 by 4.32% to 133.00 thousand RUB from 139.00 thousand RUB KAgent.Entities.Balance, the company informed.

Cost of goods sold remained at the same level amounting to 98.00 thousand RUB compared to 98.00 thousand RUB; sales loss matched the previous year’s result amounting to 98.00 thousand RUB.

Net loss (RAS) of DOK-FARMA, OOO dropped over 2021 2.27 times to 139.00 thousand RUB from 315.00 thousand RUB KAgent.Entities.Balance, the company informed.

Cost of goods sold grew by 7.69% to 98.00 thousand RUB from 91.00 thousand RUB; sales loss grew by 7.69% to 98.00 thousand RUB from 91.00 thousand RUB.

Net loss (RA) of DOK-FARMA, OOO made up 315.00 thousand RUB over 2020 compared to net profit of 19.38 million RUB over 2019, the company informed.

Revenue decreased in the accounting period ? times to 0.00 thousand RUB from 24.81 million RUB in 2019; cost of goods sold decreased 39.44 times to 91.00 thousand RUB from 3.59 million RUB; sales loss made up 91.00 thousand RUB compared to sales profit of 21.22 million RUB.

Net loss (RAS) of DOK-FARMA, OOO dropped over 2018 by 28.58% to 1.05 million RUB from 1.47 million RUB KAgent.Entities.Balance, the company informed.

Cost of goods sold decreased by 33.13% to 967.00 thousand RUB from 1.45 million RUB; sales loss decreased by 33.13% to 967.00 thousand RUB from 1.45 million RUB.

Net loss (RAS) of DOK-FARMA, OOO dropped over 2017 by 10.62% to 1.47 million RUB from 1.65 million RUB KAgent.Entities.Balance, the company informed.

Cost of goods sold decreased by 9.51% to 1.45 million RUB from 1.60 million RUB; sales loss decreased by 9.51% to 1.45 million RUB from 1.60 million RUB.

Companies in the region

• GSK "UGRESHA-20"
• ELENIYA
• SNT "SFERA"
• SCHELKOVSKIY MASTER
• ALMATIS